Project Details
| Short title | NUV-868-01 |
|---|---|
| Acronym | NUV-868-01 |
| Status | Active |
| Effective start/end date | 2/08/23 → 26/04/28 |
CTU: Phase 1/2 Safety and Efficacy Study of NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
- Park, John (Primary Chief Investigator)
- Contacos, Christine (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
Project: Research